Glen Ibbott
Vermögen: 101 448 $ am 31.05.2026
Vermögen: 101 448 $ am 31.05.2026
Glen W.
Ibbott is currently Director at Community Foundation of Ottawa, Independent Director at WM Technology, Inc. since 2024, and Chief Financial Officer & Secretary at Rubicon Organics, Inc. starting in 2025.
Former roles include Director at Childrens Hospital of Eastern Ontario Research Institute, Inc. and Peloton Pharmaceuticals, Inc.; Chief Financial Officer & Senior VP-Finance at QLT, Inc. from 2015 to 2017; Chief Financial Officer at Aurora Cannabis, Inc. from 2017 to 2024; Vice President-Finance at Nordion (Canada), Inc. from 2010 to 2014; and Chief Financial Officer & Senior Vice President at Novelion Therapeutics, Inc. Education includes undergraduate studies at Simon Fraser University, and Masters of Business Administration degrees from Queen's University and Cornell University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
RUBICON ORGANICS, INC. 0,25 % | 15.01.2026 | 170.454 ( 0,25 % ) | 54 545 $ | 31.05.2026 |
| 15.04.2026 | 117.845 ( 0,11 % ) | 46 902 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| WM TECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 01.10.2024 |
| RUBICON ORGANICS INC. | Finanzdirektor/CFO | 15.05.2025 |
Community Foundation of Ottawa | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| AURORA CANNABIS INC. | Finanzdirektor/CFO | 20.02.2024 |
Peloton Pharmaceuticals, Inc.
Peloton Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Owns and operates cannabis production facility | Direktor/Vorstandsmitglied | 30.06.2022 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Finanzdirektor/CFO | 01.04.2017 |
| NORDION INC | Finanzdirektor/CFO | 01.08.2014 |
| NOVELION THERAPEUTICS INC. | Finanzdirektor/CFO | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Nordion (Canada), Inc.
Nordion (Canada), Inc. Medical SpecialtiesHealth Technology Provides cobalt-60 and gamma irradiation system services for the medical device, food safety & health care industries | Health Technology |
Aurora Cannabis, Inc.
Aurora Cannabis, Inc. Agricultural Commodities/MillingProcess Industries Produces, distributes and sells cannabis and cannabis related products | Process Industries |
Queen's University
Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Simon Fraser University
Simon Fraser University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Community Foundation of Ottawa | |
Childrens Hospital of Eastern Ontario Research Institute, Inc.
Childrens Hospital of Eastern Ontario Research Institute, Inc. Hospital/Nursing ManagementHealth Services Operates children's hospital | Health Services |
Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Peloton Pharmaceuticals, Inc.
Peloton Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Owns and operates cannabis production facility | Health Technology |
Rubicon Organics, Inc.
Rubicon Organics, Inc. Pharmaceuticals: OtherHealth Technology Engages in producing and supplying of certified organic cannabis | Health Technology |
WM Technology, Inc.
WM Technology, Inc. Internet Software/ServicesTechnology Services Operates online marketplace which provides news articles and information about cannabis strains | Technology Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen